ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : SPECTROSCOPY
Australian State/Territory : VIC
Field of Research : Biological And Medical Chemistry
Clear All
Filter by Field of Research
Biological And Medical Chemistry (4)
Chemical Spectroscopy (4)
Physical Chemistry (Incl. Structural) (3)
Bioinorganic Chemistry (2)
Analytical Biochemistry (1)
Characterisation Of Macromolecules (1)
Inorganic Chemistry (1)
Filter by Socio-Economic Objective
Chemical sciences (4)
Treatments (e.g. chemicals, antibiotics) (3)
Diagnostic methods (2)
Infectious diseases (1)
Medical instrumentation (1)
Filter by Funding Provider
Australian Research Council (4)
Filter by Status
Closed (4)
Filter by Scheme
Discovery Projects (2)
Linkage Infrastructure, Equipment and Facilities (2)
Filter by Country
Australia (4)
Filter by Australian State/Territory
VIC (4)
NSW (2)
QLD (1)
  • Researchers (21)
  • Funded Activities (4)
  • Organisations (6)
  • Funded Activity

    Discovery Projects - Grant ID: DP0984722

    Funder
    Australian Research Council
    Funding Amount
    $995,000.00
    Summary
    Microprobe and Nanoprobe Studies on Intracellular Disease Processes and Their Treatment. Breakthrough microprobe and nanoprobe technologies, involving X-ray, visible and infrared light can focus into different components of mammalian cells in order to interrogate the biochemistry that is occurring therein. Each of the different wavelengths of light provides complementary biochemical information that enables a deeper understanding of changes in cells that occur as a function of drug treatments an .... Microprobe and Nanoprobe Studies on Intracellular Disease Processes and Their Treatment. Breakthrough microprobe and nanoprobe technologies, involving X-ray, visible and infrared light can focus into different components of mammalian cells in order to interrogate the biochemistry that is occurring therein. Each of the different wavelengths of light provides complementary biochemical information that enables a deeper understanding of changes in cells that occur as a function of drug treatments and disease processes. This will provide unprecedented information as to where drugs go and how they are transformed inside cells that, in turn, may revolutionalise the way in which new drugs are designed that have higher specificity and fewer side effects.
    Read more Read less
    More information
    Funded Activity

    Discovery Projects - Grant ID: DP0664012

    Funder
    Australian Research Council
    Funding Amount
    $290,000.00
    Summary
    Raman and synchrotron spectroscopy of nano-scale drug interactions and molecular processes in single living cells. The need for potent low-cost drugs is ever increasing, yet effective ways to screen for new drugs remain elusive. A spectroscopic approach to screening drugs in living cells would seem a logical alternative to chemically based and morphological methods that are the status quo. In this context we are developing methodology to analyse molecular target sites in single living cells for .... Raman and synchrotron spectroscopy of nano-scale drug interactions and molecular processes in single living cells. The need for potent low-cost drugs is ever increasing, yet effective ways to screen for new drugs remain elusive. A spectroscopic approach to screening drugs in living cells would seem a logical alternative to chemically based and morphological methods that are the status quo. In this context we are developing methodology to analyse molecular target sites in single living cells for two of the most devastating diseases to afflict human kind, namely malaria and cancer. New ways of rapidly screening drugs in living cells prior to clinical trials will save an enormous amount of time, money and ultimately lives.
    Read more Read less
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0560680

    Funder
    Australian Research Council
    Funding Amount
    $901,862.00
    Summary
    Vibrational Spectroscopy Microprobe/FESEM/AFM Imaging of Cells, Tissues and Materials. State-of-the-art vibrational mapping and imaging equipment (integrated with a field-emission scanning electron microscope (FESEM) and an atomic force microscope (AFM)) will provide enabling technologies for cutting-edge research in disease diagnosis, identification of pathogens, mapping of the entry and distribution of pharmaceutics into cells, and materials research. An InVia Renishaw Raman spectrometer (sub .... Vibrational Spectroscopy Microprobe/FESEM/AFM Imaging of Cells, Tissues and Materials. State-of-the-art vibrational mapping and imaging equipment (integrated with a field-emission scanning electron microscope (FESEM) and an atomic force microscope (AFM)) will provide enabling technologies for cutting-edge research in disease diagnosis, identification of pathogens, mapping of the entry and distribution of pharmaceutics into cells, and materials research. An InVia Renishaw Raman spectrometer (sub-micron spatial positioning and micron spatial resolution) will be interfaced to an FEI Quanta FESEM for combined Raman (spectroscopic), EDS and SEM (morphological) imaging/mapping at the sub-cellular level. Complementary new-generation Raman and IR spectrometer upgrades will provide an integrated world-class equipment platform.
    Read more Read less
    More information
    Funded Activity

    Linkage Infrastructure, Equipment And Facilities - Grant ID: LE0668403

    Funder
    Australian Research Council
    Funding Amount
    $570,000.00
    Summary
    Enhanced micro-Raman and Fluorescence spectroscopy and imaging facility for biosystems and materials. The state-of-the-art spectroscopic and fluorescence imaging equipment will provide cutting-edge capabilities for fundamental and applied research with the potential to impact on improved health outcomes, pharmaceutics, biotechnology and nanomaterials research. Chemical probes based on molecular vibrations and fluorescence will allow changes in biomolecular composition within cells and tissues to .... Enhanced micro-Raman and Fluorescence spectroscopy and imaging facility for biosystems and materials. The state-of-the-art spectroscopic and fluorescence imaging equipment will provide cutting-edge capabilities for fundamental and applied research with the potential to impact on improved health outcomes, pharmaceutics, biotechnology and nanomaterials research. Chemical probes based on molecular vibrations and fluorescence will allow changes in biomolecular composition within cells and tissues to be mapped/imaged down to nanometre spatial resolution. This will provide new techniques for the diagnosis of diseases, e.g. cancer, the rapid identification of pathogens, the understanding and design of new drugs, and a range of biotechnology, nanomaterials and nanotechnology applications.
    Read more Read less
    More information

    Showing 1-4 of 4 Funded Activites

    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback